SCLERO.ORG is retiring 4-24-2021. Thank you for the memories! You'll still find us in the Wayback Machine, and we'll carry your stories in our hearts forever.
Scleroderma Newsroom
ISN News Manager: Jo Frowde
Media Stories
Autoimmune Archive
We maintain news archives for the most recent 3 years.
2019: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021 - 2020 - 2019 - 2018

July 2019 Autoimmune News

Critical role of neutrophil extracellular traps (NETs) in patients with Behçet's disease . Our data show that NETs and markers of NETS levels are elevated in patients with BD and contribute to the procoagulant state. PubMed, Ann Rheum Dis, 05/30/2019. (Also see Behçet's Disease)

Changing hospitalization trends for systemic lupus erythematosus (SLE) and rheumatoid arthritis in England. Whilst all-cause emergency admissions rose in the general population, those for SLE fell. PubMed, Lupus, 2019 Jun 4:961203319853357. (Also see Systemic Lupus Erythematosus and Rheumatoid Arthritis)

Opportunistic screening for osteoporosis using thoraco-abdomino-pelvic CT-scan assessing the vertebral density in rheumatoid arthritis patients. CT offers a combined opportunistic screening for osteoporosis by assessing both vertebral fractures and bone density on routine CT-scans. PubMed, Osteoporos Int, 2019 Jun;30(6):1215-1222. (Also see Osteoporosis and Symptoms and Complications of Rheumatoid Arthritis)

Association Between Psoriasis with Arthritis (PsA) and Hearing Impairment (HI) in US Adults: Data from the National Health and Nutrition Examination Survey. PsA is independently associated with a significantly increased risk of HI, which partially mediates an association with worsened psychiatric outcomes. PubMed, J Rheumatol, 2019 Jun;46(6):587-594. (Also see Psoriasis and Psoriatic Arthritis)

A System to Determine Risk of Osteoporosis in Patients With Autoimmune Hepatitis. Almost 20% of patients with AIH older than 50 years have osteoporosis. PubMed, Clin Gastroenterol Hepatol, 06/01/2019. (Also see Osteoporosis and Liver and Spleen Involvement)

Factors of importance for reducing fatigue in persons with rheumatoid arthritis: a qualitative interview study. The participants in this study expressed that physical activity was important in handling fatigue, but also that this insight could only come from personal experience. PubMed, BMJ Open, 2019 May 29;9(5):e028719. (Also see Symptoms and Complications of Rheumatoid Arthritis)

Tapering biologic therapy for people with rheumatoid arthritis in remission: A review of patient perspectives and associated clinical evidence. More research is needed on tapering biologics, and should include studies of patient perspectives as well as health economic evaluations. PubMed, Musculoskeletal Care, 05/30/2019. (Also see Treatments for Rheumatoid Arthritis)

The RIG-I pathway is involved in peripheral T cell lymphopenia in patients with dermatomyositis (DM). Our study showed for the first time that negative correlation between the increased RIG-I expression in peripheral T lymphocyte and T cell count in some patients with DM. PubMed, Arthritis Res Ther, 2019 May 29;21(1):131. (Also see Dermatomyositis and Polymyositis)

Association between histopathologic changes and expression of selected microRNAs in skin of adult patients with IgA vasculitis. Further investigation of miRNAs expression in the affected tissues could improve knowledge of IgAV pathogenesis and possibly help to identify novel biomarkers in body fluids. PubMed, Histopathology, 05/28/2019. (Also see Vasculitis)

Obstetric outcomes in patients with primary thrombotic and obstetric antiphospholipid syndrome and its relation to the antiphospholipid antibody profile. Patients with primary antiphospholipid syndrome, especially those with obstetric antiphospholipid syndrome and triple antibody positivity, are at higher risk for adverse pregnancy outcomes. PubMed, Lupus, 2019 May 27:961203319852155. (Also see Antiphospholipid Syndrome)

Go to Autoimmune News: June 2019

SCLERO.ORG is the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses. We are a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team. Donations may also be mailed to:

International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA
Email [email protected]. Disclaimer. Privacy Policy.